NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 171 filers reported holding NXSTAGE MEDICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,163,000 | +1.2% | 117,890 | -1.1% | 0.01% | 0.0% |
| Q4 2016 | $3,125,000 | +6.1% | 119,216 | +1.2% | 0.01% | 0.0% |
| Q3 2016 | $2,945,000 | -47.6% | 117,824 | -54.6% | 0.01% | -50.0% |
| Q2 2016 | $5,625,000 | +135.7% | 259,467 | +63.0% | 0.02% | +125.0% |
| Q1 2016 | $2,387,000 | -76.6% | 159,217 | -65.8% | 0.01% | -74.2% |
| Q4 2015 | $10,190,000 | +56.6% | 465,103 | +12.7% | 0.03% | +55.0% |
| Q3 2015 | $6,507,000 | -67.8% | 412,666 | -70.8% | 0.02% | -62.3% |
| Q2 2015 | $20,181,000 | -56.0% | 1,412,673 | -46.7% | 0.05% | -54.3% |
| Q1 2015 | $45,840,000 | -13.9% | 2,649,751 | -10.8% | 0.12% | -14.1% |
| Q4 2014 | $53,264,000 | +805.2% | 2,970,646 | +562.9% | 0.14% | +800.0% |
| Q3 2014 | $5,884,000 | -21.5% | 448,137 | -14.1% | 0.02% | +66.7% |
| Q2 2014 | $7,492,000 | – | 521,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |